ArticleMolecular cancer therapeutics2012

Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.

Xinyi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.